Barely Significant
← all excerpts

Efficacy and safety of toripalimab in the treatment of nasopharyngeal carcinoma: a meta-analysis of single-arm trials.

BMC Immunol · 2025 · PMC12379329 · PMID 40855414

1
hedged sentence
closest p
boldest claim

The sentences

may be significantno p-value reported
According to the results of this single-arm meta-analysis, although toripalimab showed some efficacy in the treatment of nasopharyngeal cancer, the high heterogeneity suggests that there may be significant differences between studies, affecting the reliability of their results.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.